PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28993090-11 2018 TAC-induced protein overexpression of monocyte chemoattractant protein-1, and mRNA overexpression of tumor necrosis factor-alpha, interleukin (IL)-1beta and IL-6 in the left atrium was suppressed by RVX treatment. Rivaroxaban 199-202 tumor necrosis factor Mus musculus 101-128 33693223-8 2020 Rivaroxaban also downregulated the mRNA expression levels of tumor necrosis factor-alpha, transforming growth factor-beta, PAR-1 and PAR-2 in the infarcted area, and both A-type and B-type natriuretic peptides in the non-infarcted area compared with the vehicle. Rivaroxaban 0-11 tumor necrosis factor Mus musculus 61-88 30210674-5 2018 The levels of tumor necrosis factor alpha, interleukin 1 beta, and interleukin 6, as well as total protein and Evans blue concentrations, were all significantly reduced in bronchoalveolar lavage fluid from mice treated with rivaroxaban. Rivaroxaban 224-235 tumor necrosis factor Mus musculus 14-41 21772662-7 2011 Real time-PCR from thoracic aortas revealed that rivaroxaban (5 mg/kg/day) treatment reduced mRNA expression of inflammatory mediators, such of IL-6, TNF-alpha, MCP-1, and Egr-1 (P < .05). Rivaroxaban 49-60 tumor necrosis factor Mus musculus 150-159 26370374-6 2015 In mouse cytokine array measuring 40 cytokines, the productions of interleukin-16, TIMP-1, and tumor necrosis factor-alpha (TNF-alpha) were significantly reduced with 0.1 mug/mL of rivaroxaban pretreatment (all P < 0.05). Rivaroxaban 181-192 tumor necrosis factor Mus musculus 95-122 26370374-6 2015 In mouse cytokine array measuring 40 cytokines, the productions of interleukin-16, TIMP-1, and tumor necrosis factor-alpha (TNF-alpha) were significantly reduced with 0.1 mug/mL of rivaroxaban pretreatment (all P < 0.05). Rivaroxaban 181-192 tumor necrosis factor Mus musculus 124-133 29269019-7 2018 Quantitative RT-PCR analyses demonstrated that rivaroxaban reduced the expression of inflammatory molecules (e.g., IL-1beta and TNF-alpha) in injured arteries at seven days after surgery (P<0.05, respectively). Rivaroxaban 47-58 tumor necrosis factor Mus musculus 128-137 29269019-8 2018 In vitro experiments using mouse peritoneal macrophages demonstrated that FXa increased the expression of inflammatory molecules (e.g., IL-1beta and TNF-alpha), which was blocked in the presence of rivaroxaban (P<0.05). Rivaroxaban 198-209 tumor necrosis factor Mus musculus 149-158